Ultralife Corporation Files Form 12b-25 Notification of Late Filing
Ultralife (NASDAQ: ULBI) has filed a Form 12b-25 with the SEC, notifying a delay in submitting its Annual Report on Form 10-K for fiscal year 2024. The delay is attributed to the ongoing completion of accounting close and financial results audit of Electrochem Solutions, Inc., which was acquired on October 31, 2024.
The company expects to file its Form 10-K no later than April 1, 2025. Consequently, Ultralife will reschedule its previously planned fourth quarter and fiscal year 2024 earnings release and conference call from March 11, 2025. The new date will be announced once the Form 10-K filing date is confirmed.
Ultralife (NASDAQ: ULBI) ha presentato un modulo 12b-25 alla SEC, notificando un ritardo nella presentazione del suo Rapporto Annuale sul Modulo 10-K per l'anno fiscale 2024. Il ritardo è attribuito al completamento in corso della chiusura contabile e dell'audit dei risultati finanziari di Electrochem Solutions, Inc., acquisita il 31 ottobre 2024.
L'azienda prevede di presentare il suo Modulo 10-K entro e non oltre il 1 aprile 2025. Di conseguenza, Ultralife riprogrammerà il rilascio dei risultati del quarto trimestre e dell'anno fiscale 2024, precedentemente pianificato per l'11 marzo 2025. La nuova data sarà annunciata una volta confermata la data di presentazione del Modulo 10-K.
Ultralife (NASDAQ: ULBI) ha presentado un formulario 12b-25 ante la SEC, notificando un retraso en la presentación de su Informe Anual en el Formulario 10-K para el año fiscal 2024. El retraso se atribuye a la finalización en curso del cierre contable y de la auditoría de resultados financieros de Electrochem Solutions, Inc., que fue adquirida el 31 de octubre de 2024.
La compañía espera presentar su Formulario 10-K a más tardar el 1 de abril de 2025. En consecuencia, Ultralife reprogramará la publicación de resultados del cuarto trimestre y del año fiscal 2024, que estaba prevista para el 11 de marzo de 2025. La nueva fecha se anunciará una vez que se confirme la fecha de presentación del Formulario 10-K.
Ultralife (NASDAQ: ULBI)는 SEC에 12b-25 양식을 제출하여 2024 회계연도에 대한 10-K 양식 연례 보고서 제출이 지연됨을 통지했습니다. 이 지연은 Electrochem Solutions, Inc.의 회계 마감 및 재무 결과 감사 완료가 진행 중인 것에 기인합니다. 이 회사는 2024년 10월 31일에 인수되었습니다.
회사는 2025년 4월 1일 이전에 10-K 양식을 제출할 것으로 예상합니다. 따라서 Ultralife는 2025년 3월 11일로 예정된 2024 회계연도 및 4분기 실적 발표 및 컨퍼런스 콜 일정을 재조정할 것입니다. 새로운 날짜는 10-K 양식 제출 날짜가 확인되는 대로 발표될 것입니다.
Ultralife (NASDAQ: ULBI) a déposé un formulaire 12b-25 auprès de la SEC, notifiant un retard dans la soumission de son Rapport Annuel sur le Formulaire 10-K pour l'exercice 2024. Ce retard est attribué à l'achèvement en cours de la clôture comptable et de l'audit des résultats financiers de Electrochem Solutions, Inc., qui a été acquis le 31 octobre 2024.
La société prévoit de soumettre son Formulaire 10-K au plus tard le 1er avril 2025. Par conséquent, Ultralife reprogrammera la publication de ses résultats du quatrième trimestre et de l'exercice 2024, initialement prévue pour le 11 mars 2025. La nouvelle date sera annoncée une fois que la date de soumission du Formulaire 10-K sera confirmée.
Ultralife (NASDAQ: ULBI) hat ein Formular 12b-25 bei der SEC eingereicht und einen Verzögerung bei der Einreichung seines Jahresberichts im Formular 10-K für das Geschäftsjahr 2024 mitgeteilt. Die Verzögerung wird auf den laufenden Abschluss der Buchhaltung und die Prüfung der finanziellen Ergebnisse von Electrochem Solutions, Inc. zurückgeführt, die am 31. Oktober 2024 übernommen wurde.
Das Unternehmen erwartet, sein Formular 10-K spätestens bis zum 1. April 2025 einzureichen. Folglich wird Ultralife die zuvor geplante Veröffentlichung der Ergebnisse für das vierte Quartal und das Geschäftsjahr 2024, die für den 11. März 2025 vorgesehen war, neu terminieren. Das neue Datum wird bekannt gegeben, sobald das Einreichungsdatum des Formulars 10-K bestätigt ist.
- Company complying with SEC regulations by filing Form 12b-25
- Recent acquisition of Electrochem Solutions expands business portfolio
- Delay in filing annual 10-K report indicates potential accounting complexities
- Postponement of Q4 and FY2024 earnings release creates uncertainty
NEWARK, N.Y., March 07, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI), today announced that it has filed a Form 12b-25, Notification of Late Filing, with the Securities and Exchange Commission in connection with its Annual Report on Form 10-K for the fiscal year ended December 31, 2024.
The extension is necessary to allow for the completion of the accounting close and financial results audit of Electrochem Solutions, Inc., which the Company acquired on October 31, 2024. The Company expects to file its Form 10-K with the Securities and Exchange Commission as soon as practicable, and no later than April 1, 2025, in accordance with Rule 12b-25.
In addition, the Company will reschedule its earnings release and conference call for the fourth quarter and fiscal year 2024, previously scheduled for Tuesday, March 11, 2025, and announce the date and time of the rescheduled earnings release and call once the filing date of its Form 10-K is confirmed.
About Ultralife Corporation
Ultralife Corporation serves its markets with products and services ranging from power solutions to communications and electronics systems. Through its engineering and collaborative approach to problem solving, Ultralife serves government/defense and commercial customers across the globe.
Headquartered in Newark, New York, the Company's business segments include Battery & Energy Products and Communications Systems. Ultralife has operations in North America, Europe and Asia. For more information, visit www.ultralifecorporation.com.
| Company Contact: Ultralife Corporation Philip A. Fain (315) 210-6110 pfain@ulbi.com | Investor Relations Contact: Alliance Advisors IR Jody Burfening/Alex Villalta (212) 838-3777 avillalta@allianceadvisors.com |
FAQ
Why is Ultralife (ULBI) delaying its 2024 Form 10-K filing?
When will Ultralife (ULBI) file its delayed 2024 Form 10-K?
What impact does the Form 12b-25 filing have on ULBI's earnings release?
When did ULBI acquire Electrochem Solutions, Inc.?
